AMRX vs FIS · P/E 44, rev $1.52B vs P/E 7.9, rev $6.67B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Fidelity National Information Services Inc (FIS) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Not investment advice. Open the AMRX and FIS stock pages for the full models.
Not investment advice.